Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Dipak S. Pisal
Observed names:
D. Pisal,
Dipak Pisal,
Dipak S Pisal
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
Observed institutions:
United States Food and Drug Administration,
State University of New York,
Center for Drug Evaluation and Research,
South Dakota State University,
AbbVie (United States),
University at Buffalo, State University of New York
show all 6
ORCID:
0009-0003-0551-3892
Observed ORCID:
0009-0003-0551-3892
OpenAlex ID:
A5086033292
Delivery of Therapeutic Proteins
2010
·
Dipak S. Pisal
, Matthew P. Kosloski
, et al.
·
Journal of Pharmaceutical Sciences
·
589
Carotenoid production from microalga, Dunaliella salina
2005
·
Dipak S Pisal
, S. S. Lele
·
143
Permeability of surface-modified polyamidoamine (PAMAM) dendrimers across Caco-2 cell monolayers
2007
·
Dipak S. Pisal
, Venkata K. Yellepeddi
, et al.
·
International Journal of Pharmaceutics
·
62
Native-Like Aggregates of Factor VIII Are Immunogenic in von Willebrand Factor Deficient and Hemophilia a Mice
2012
·
Dipak S. Pisal
, Matthew P. Kosloski
, et al.
·
Journal of Pharmaceutical Sciences
·
48
Phosphatidylinositol induces fluid phase formation and packing defects in phosphatidylcholine model membranes
2011
·
Aaron Peng
, Dipak S. Pisal
, et al.
·
Chemistry and Physics of Lipids
·
47
Transport of Surface Engineered Polyamidoamine (PAMAM) Dendrimers Across IPEC-J2 Cell Monolayers
2008
·
Dipak S. Pisal
, Venkata K. Yellepeddi
, et al.
·
Drug Delivery
·
28
PDF
Phospholipid binding improves plasma survival of factor VIII
2010
·
Dipak Pisal
, Sathy Balu-Iyer
·
Thrombosis and Haemostasis
·
19
PDF
Use of a folding model and in situ spectroscopic techniques for rational formulation development and stability testing of monoclonal antibody therapeutics**Gauri Rao and Vandana Iyer contributed equally to this work.
2009
·
Gauri Rao
, Vandana Iyer
, et al.
·
Journal of Pharmaceutical Sciences
·
14
FRI0164 Safety, Tolerability, And Functional Activity of ABT-122, A Dual TNF- and IL-17A–Targeted DVD-IG™, Following Single-Dose Administration in Healthy Subjects
2015
·
H. Mansikka
, M. Ruzek
, et al.
·
Annals of the Rheumatic Diseases
·
12
A Novel Pharmacokinetic Bridging Strategy to Support a Change in the Route of Administration for Biologics
2019
·
Ping Ji
, Nikolay Nikolov
, et al.
·
Journal of Pharmaceutical Sciences
·
10
Nonlinear pharmacokinetics of factor VIII and its phosphatidylinositol lipidic complex in hemophilia A mice
2013
·
Matthew P. Kosloski
, Dipak S. Pisal
, et al.
·
Biopharmaceutics & Drug Disposition
·
8
Allometry of Factor VIII and Informed Scaling of Next-Generation Therapeutic Proteins
2013
·
Matthew P. Kosloski
, Dipak S. Pisal
, et al.
·
Journal of Pharmaceutical Sciences
·
8
Model‐Informed Drug Development‐Based Approval of Intravenous Secukinumab for the Treatment of Adult Patients with Active Psoriatic Arthritis, Active Ankylosing Spondylitis, and Active Non‐Radiographic Axial Spondyloarthritis
2024
·
Dipak S. Pisal
, Yangbing Li
, et al.
·
Clinical Pharmacology & Therapeutics
·
6
PDF
Food and Drug Administration regulation of biosimilar products: Improving affordability of biologics for patients with asthma and allergic diseases
2026
·
Sabiha Khan
, Thomas M. Herndon
, et al.
·
Journal of Allergy and Clinical Immunology
·
4
Impact of Switching on Pharmacokinetics of Therapeutic Biologics and Interchangeability Assessment—A Simulation Study
2021
·
Ping Ji
, Yupeng Ren
, et al.
·
The Journal of Clinical Pharmacology
·
4
Phospholipid binding lowers immunogenicity of human recombinant factor VIII in von Willebrand factor knockout mice
2011
·
Dipak Pisal
, Sathy Balu-Iyer
·
Thrombosis and Haemostasis
·
1
PDF
Integrating Patient‐Centric Clinical Pharmacology and MID3 to Advance Biologic Development in Immune‐Mediated Inflammatory Diseases
2026
·
Sihem Ait‐Oudhia
, Li Zhang
, et al.
·
Clinical Pharmacology & Therapeutics
PDF
Show more works
View as search
Works count:
17
Citation count:
1,003
H-index:
10
I10-index:
10
Year
Topic
Type